info@medicoverhospitals.in
Dr G Ranga Raman
MBBS, MD, DM(Medical Oncology), ICMLF
Sr. Consultant Medical Oncologist
Experience: 5 Years
Nellore
Timings : Mon-Sat: 10am-5pm
About Doctor:
- Chemotherapy
- Targeted therapy Immunotherapy
- Colon & GI Cancer
- Kidney & GU Cancer
- Breast Cancer Treatment
- Lung cancer
- Leukemia
- Lymphoma
- Myeloma
- Pediatric oncology
- Cancer Screening
- Ovary Cancer
- Bone Cancer
- Thyroid Cancer Palliative treatment Transplant
- Stem Cell Transplantation
- Genitourinary Cancer
- SGPGI : Hematology; PDT(2010 - 2010)
- NRSMCH: Hematology; PDT (2011 - 2011)
- BIACRI: Medical Oncology ; Jr. Consultant (2012-2012)
- NIMS Medical Oncology ; DM Resident (2013-2015)
- HCG Curie Cancer Centre: Medical Oncology ; Head of Department (2015-2021)
- Medicover Cancer Institute: Medical Oncology; Senoir Consultant (2021- to present)
- Outcomes in pediatric CML in a developing country – Beyond the disease biology”. journal of Clinical oncology 32,2014, no.15_suppl e21005 .
- Prognostic significance of NLR kinetics in operable triple negative breast cancer. e14201 journal of Clinical oncology 37,2019, no.15_suppl.
- Cytogenetic and molecular response rates in AYA CML CP patients on imatinib based on the baseline BMI”, Annals of Oncology, Volume 27, Issue suppl_9, December 2016, mdw586.009,
- Is rituximab-based chemotherapy a standard practice in the treatment of B-NHLs in the developing world. journal of Clinical oncology 31,2013_suppl e19533
- Secondary malignancies in CML patients: a retrospective analysis from tertiary care center in India” Annals of Oncology, Volume 26, Issue suppl_9, 1 December 2015, Page ix92,
- American Society of Clinical Oncology (Asco) – Member
- European Society of Medical Oncology (Esmo) – Ismpo, Ics, Iosi Member
- English
- Telugu
- Hindi
Copyrights © 2022 All Rights Reserved by Medicover Hospitals (A Unit of Sahrudaya Health Care Private Limited)
